Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127165) titled 'A quantitative DCE-MRI-based multi-omics model for predicting immune microenvironment characteristics and prognosis of triple-negative breast cancer' on June 25.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Condition:
Breast cancer
Recruitment Status: Recruiting
Phase: 0
Date of First Enrollment: 2026-06-08
Target Sample Size: High FAP+ Group and Low FAP+ Group:160;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=329366
Published by HT Digita...